CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH The FDA-approved device is the first of its kind to relieve action tremor (tremor during intentional movement) in Parkinson’s patients.
Innovative healthcare technology is once again making headlines as a new wearable device, akin to a wristwatch, offers hope to individuals living with Parkinson’s disease, offering a novel approach to controlling tremor.
Key Points:
- The Cala kIQ System, a wearable device, is now available in the US for managing tremors in Parkinson’s disease.
- The Cala kIQ System is also indicated for use in essential tremor, another condition causing hand shaking.
- Veterans Affairs (VA) health systems will provide this device at no cost to VA beneficiaries who are prescribed it.
Additional Points:
- The device functions based on principles similar to deep brain stimulation (DBS), delivering electrical stimulation to specific brain regions via nerves in the arm.
- The kIQ System uses artificial intelligence to personalize the amount of stimulation based on individual tremor patterns and record patient data.
- Cala Health, the developer, is reportedly seeking additional coverage options for the device.
Conclusion:
- The introduction of the Cala kIQ System may revolutionize the management of action tremors in Parkinson’s patients, offering a non-invasive alternative to surgical options like deep brain stimulation.
Neurology Latest Posts
- A List of Drugs Linked to Dementia
- Autism Spectrum Disorder: Symptoms, Causes, Treatments, and Natural Approaches
- High-potency Cannabis Use is Tied to Epigenetic Changes, Study Suggests
- Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy
“There’s a real need for patient populations who suffer from action hand tremors to have an effective, safe option when it comes to managing their symptoms – which is exactly where TAPS [Transcutaneous Afferent Patterned Stimulation] therapy can come in and make a profound difference.”
Pravin Khemani, MD
Consultant
Cala Health
